The CAR T-Cell Therapy Transformation: Understanding the Technology, Current Landscape, and Future Directions Read more about The CAR T-Cell Therapy Transformation: Understanding the Technology, Current Landscape, and Future Directions
How Time Is Accounted for When Modeling Pharmaceutical Impacts: Investment vs. Assessment Perspectives Read more about How Time Is Accounted for When Modeling Pharmaceutical Impacts: Investment vs. Assessment Perspectives
Inflation Reduction Act Impact on Pharmaceutical Investment: Insights From Investor Interviews Read more about Inflation Reduction Act Impact on Pharmaceutical Investment: Insights From Investor Interviews
77% of Investors Say IRA's "Pill Penalty" Disincentivizes Small Molecule Investments Read more about 77% of Investors Say IRA's "Pill Penalty" Disincentivizes Small Molecule Investments
Research Finds That Post-Approval Cancer Trials Fell After IRA Passage, With Disproportionate Impact on Small Molecule Drugs Read more about Research Finds That Post-Approval Cancer Trials Fell After IRA Passage, With Disproportionate Impact on Small Molecule Drugs
Early Impact of the Inflation Reduction Act on Small Molecule vs Biologic Post-Approval Oncology Trials Read more about Early Impact of the Inflation Reduction Act on Small Molecule vs Biologic Post-Approval Oncology Trials
House Hearing Highlights NPC Research on IRA Impact on Orphan Drugs Read more about House Hearing Highlights NPC Research on IRA Impact on Orphan Drugs
Whittington, Garrison, and Campbell: Challenges with Judging and Interpreting a Drug’s Launch Price (AJMC Commentary) Read more about Whittington, Garrison, and Campbell: Challenges with Judging and Interpreting a Drug’s Launch Price (AJMC Commentary)
Challenges With Judging and Interpreting a Drug’s Launch Price Read more about Challenges With Judging and Interpreting a Drug’s Launch Price